Licensing, partnering, and other collaborative opportunities
Our goal at the Center for Synthetic Immunity is to develop novel therapeutics and get them into the clinic to benefit patients
We are interested in discussing possible collaborations for scientific and development projects with potential academic, industry, and financial partners.
If you would like more information about ongoing research or career opportunities at the Center for Synthetic Immunity, please contact us.
For licensing, partnering, philanthropic support or other opportunities to work with the CSI research team, please contact us by email ([email protected]) or by phone at (603) 646-5392.
All licensing and collaborations are managed by the policies of Dartmouth College and the Geisel School of Medicine through the Office of Sponsored Research and the Technology Transfer Office at Dartmouth.
Funding sources: NIA, NINDS, NCI, NIAID, NHLBI, CDMRP/DOD, Celdara Medical
Industry Partners
We have been involved in creating the following Biotech Startups
- Oncyte LLC – focused on oncology. Acquired by Celyad in 2015.
- Black Bear Bio LLC – focused on neurodegenerative diseases.